$24.99
+0 (+0%)
At Close: Jul 31, 2026
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
10:22am, Tuesday, 13'th May 2025
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
New Strong Sell Stocks for May 9th
07:55am, Friday, 09'th May 2025
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
01:50pm, Wednesday, 07'th May 2025
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
02:38pm, Tuesday, 06'th May 2025
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
09:25am, Tuesday, 06'th May 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
Avanos Medical, Inc. Announces First Quarter 2025 Results
07:00am, Tuesday, 06'th May 2025
ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
07:47am, Monday, 28'th Apr 2025
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on�
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
08:55am, Thursday, 03'rd Apr 2025
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
07:00am, Wednesday, 02'nd Apr 2025
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distr
New Strong Sell Stocks for March 24th
06:30am, Monday, 24'th Mar 2025
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
New Strong Sell Stocks for March 18th
09:00am, Tuesday, 18'th Mar 2025
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer
07:30am, Monday, 17'th Mar 2025
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive of
New Strong Sell Stocks for March 3rd
07:50am, Monday, 03'rd Mar 2025
AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025.
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
10:46am, Thursday, 27'th Feb 2025
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
12:41pm, Wednesday, 26'th Feb 2025
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner -
Sign In
Buy AVNS